Segall Bryant & Hamill’s Zimmer Biomet ZBH Stock Holding History

Segall Bryant & Hamill’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,387	Closed	-$639K	–	717
2023 Q2	$639K	Sell	4,387 -10	-0.2%	-$1.36K	0.01%	537
2023 Q1	$568K	Buy	4,397 +20	+0.5%	+$2.51K	0.01%	550
2022 Q4	$558K	Sell	4,377 -291	-6%	-$33.8K	0.01%	554
2022 Q3	$486K	Sell	4,668 -138	-3%	-$15.1K	0.01%	581
2022 Q2	$507K	Buy	4,806 +25	+0.5%	+$2.97K	0.01%	572
2022 Q1	$612K	Sell	4,781 -143	-3%	-$17.2K	0.01%	574
2021 Q4	$608K	Buy	4,924 +58	+1%	+$7.59K	0.01%	497
2021 Q3	$691K	Buy	4,866 +24	+0.5%	+$3.53K	0.01%	581
2021 Q2	$754K	Hold	4,842	–	–	0.01%	550
2021 Q1	$752K	Buy	4,842 +193	+4%	+$29.9K	0.01%	590
2020 Q4	$694K	Sell	4,649 -428	-8%	-$60.5K	0.01%	517
2020 Q3	$674K	Buy	5,077 +26	+0.5%	+$3.4K	0.01%	504
2020 Q2	$587K	Sell	5,051 -41	-0.8%	-$4.72K	0.01%	554
2020 Q1	$498K	Hold	5,092	–	–	0.01%	593
2019 Q4	$739K	Hold	5,092	–	–	0.01%	586
2019 Q3	$677K	Hold	5,092	–	–	0.01%	595
2019 Q2	$585K	Hold	5,092	–	–	0.01%	637
2019 Q1	$632K	Sell	5,092 -472	-8%	-$53.6K	0.01%	619
2018 Q4	$560K	Buy	5,564 +874	+19%	+$98.3K	0.01%	630
2018 Q3	$599K	Sell	4,690 -411	-8%	-$48.9K	0.01%	642
2018 Q2	$552K	Buy	5,101 +411	+9%	+$44.7K	0.01%	656
2018 Q1	$496K	Sell	4,690 -2,364	-34%	-$275K	0.01%	438
2017 Q4	$826K	Sell	7,054 -640	-8%	-$72.4K	0.02%	360
2017 Q3	$875K	Sell	7,694 -1,964	-20%	-$227K	0.02%	373
2017 Q2	$1.2M	Buy	9,658 +110	+1%	+$13K	0.03%	349
2017 Q1	$1.13M	Buy	9,548 +2,835	+42%	+$321K	0.03%	339
2016 Q4	$673K	Sell	6,713 -1,262	-16%	-$135K	0.02%	387
2016 Q3	$1.01M	Buy	7,975 +1,444	+22%	+$178K	0.03%	349
2016 Q2	$763K	Buy	6,531 +1,924	+42%	+$218K	0.02%	375
2016 Q1	$477K	Hold	4,607	–	–	0.01%	417
2015 Q4	$459K	Hold	4,607	–	–	0.01%	415
2015 Q3	$420K	Hold	4,607	–	–	0.01%	433
2015 Q2	$489K	Hold	4,607	–	–	0.01%	426
2015 Q1	$526K	Sell	4,607 -77	-2%	-$8.79K	0.01%	421
2014 Q4	$516K	Buy	4,684 +77	+2%	+$8.12K	0.01%	421
2014 Q3	$450K	Buy	4,607 +329	+8%	+$32.4K	0.01%	440
2014 Q2	$431K	Sell	4,278 -147	-3%	-$14.3K	0.01%	452
2014 Q1	$406K	Sell	4,425 -1,145	-21%	-$106K	0.01%	467
2013 Q4	$504K	Hold	5,570	–	–	0.01%	437
2013 Q3	$444K	Sell	5,570 -247	-4%	-$19.4K	0.01%	450
2013 Q2	$423K	Buy	+5,817	New	+$435K	0.01%	424

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Segall Bryant & Hamill's ZBH Position: Q3 2023 in Review

Segall Bryant & Hamill sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 4,387 shares — an estimated $639K sold.

Segall Bryant & Hamill first reported a position in ZBH in Q2 2013 and held it in 41 quarters. The position peaked at $1.2M in Q2 2017. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Segall Bryant & Hamill reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Segall Bryant & Hamill sold 4,387 Zimmer Biomet shares in Q3 2023, an estimated $639K.
Segall Bryant & Hamill first reported a position in Zimmer Biomet in Q2 2013 and held it in 41 quarters.
Segall Bryant & Hamill's Zimmer Biomet position peaked at $1.2M in Q2 2017.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.